| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/26/2002 | CN1355021A Percutaneous medicine of strychnine (toxiferine or securinine) and salt thereof |
| 06/26/2002 | CN1086580C Antipruritic ointment for dermatitis |
| 06/25/2002 | US6410824 Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 06/25/2002 | US6410790 Analgesics |
| 06/25/2002 | US6410752 Tocopherol derivatives and method for preparation thereof |
| 06/25/2002 | US6410728 Oxazolidinone chemotherapeutic agents |
| 06/25/2002 | US6410709 Polypeptide; for use in diagnosis and treatment of inflammatory and cell proliferative disorders |
| 06/25/2002 | US6410599 Mixture of benzalkonium chloride, water and isopropanol |
| 06/25/2002 | US6410593 Antidandruff compositions |
| 06/25/2002 | US6410590 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 06/25/2002 | US6410588 Use of cannabinoids as anti-inflammatory agents |
| 06/25/2002 | US6410557 Spirooxathiolane quinuclidine derivatives useful as drugs which promote the secretion of sebaceous and sweat glands through oral or parenteral administration |
| 06/25/2002 | US6410551 Bronchodilator |
| 06/25/2002 | US6410540 Inhibitors of p38-αkinase |
| 06/25/2002 | US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents |
| 06/25/2002 | US6410512 Inhibitors of proteasomal activity for stimulating hair growth |
| 06/25/2002 | US6410322 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 06/25/2002 | US6410288 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
| 06/25/2002 | US6410062 Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
| 06/25/2002 | US6410040 Dissolving poly(2-propenal, 2-propenoic acid) in aqueous base, adding compound containing one or more hydrophobic groups, acidifying solution, whereby interaction between compound and polymer prevents precipitation over broad ph range |
| 06/25/2002 | US6410019 Topical administration of immunoglobulins brings about remission of inflammatory process without causing any toxic or unwanted side effects |
| 06/25/2002 | US6409995 Sunscreen |
| 06/25/2002 | CA2213609C New compounds to modulate hormone receptors, compositions containing them, and their therapeutic use |
| 06/25/2002 | CA2017379C Purification and characterization of a glioma-derived growth factor |
| 06/21/2002 | CA2365818A1 Personal care compositions |
| 06/21/2002 | CA2365660A1 Treatment for skin |
| 06/21/2002 | CA2365647A1 Method for reducing the appearance of dark circles under the eyes |
| 06/21/2002 | CA2363799A1 Novel methods for using alkanoyloxymethyl esters |
| 06/21/2002 | CA2363758A1 Novel delta dicarbonyl compounds and methods for using same |
| 06/20/2002 | WO2002048358A2 Regulation of human chemokine-like receptor |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048179A1 Gamma-ketoacid dipeptide derivatives as inhibitors of caspase-3 |
| 06/20/2002 | WO2002048136A1 Keratinocyte proliferation inhibitors |
| 06/20/2002 | WO2002048124A2 Piperazine derivatives |
| 06/20/2002 | WO2002048117A1 Quinazolinone derivatives |
| 06/20/2002 | WO2002048107A1 Antitumoral carbazoles |
| 06/20/2002 | WO2002047762A1 Serine protease inhibitors |
| 06/20/2002 | WO2002047730A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | WO2002047728A2 Treatment of posterior capsule opacification |
| 06/20/2002 | WO2002047722A1 Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof |
| 06/20/2002 | WO2002047711A2 Modulators of activity of g-protein-coupled receptor kinases |
| 06/20/2002 | WO2002047710A2 Use of inhibitors of lyn-associated signal transduction (last) in the treatment of prostate cancer |
| 06/20/2002 | WO2002047708A2 Selective cox-2 inhibition from edible plant extracts |
| 06/20/2002 | WO2002047705A2 Compositions containing an active fraction isolated from tricholoma conglobatum and methods of use |
| 06/20/2002 | WO2002047704A1 Herbal pharmaceutical compositions for treating immunological disorders |
| 06/20/2002 | WO2002047701A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 06/20/2002 | WO2002047686A1 Substituted-4-quinolones |
| 06/20/2002 | WO2002047673A2 Methods and compositions to treat conditions associated with neovascularization |
| 06/20/2002 | WO2002047656A1 Compositions for retarding skin aging |
| 06/20/2002 | WO2002047655A1 Composition, in particular cosmetic, comprising 7-hydroxy dhea or 7-keto dhea and at least a no-synthase inhibitor |
| 06/20/2002 | WO2002047653A2 Cosmetic or dermo-pharmaceutical compositions containing four o'clock (mirabilis jalapa) plant extracts |
| 06/20/2002 | WO2002047651A1 USE OF 7-HYDROXY DHEA AND/OR 7-KETO DHEA FOR TREATING DISORDERS RELATED TO EXCESSIVE 5α-REDUCTASE ACTIVITY |
| 06/20/2002 | WO2002047649A1 Composition containing 7-hydroxy dhea and/or 7-keto dhea and at least a carotenoid |
| 06/20/2002 | WO2002047645A1 Composition containing 7-hydroxy dhea and/or 7-keto dhea and at least a peeling agent |
| 06/20/2002 | WO2002047644A1 COMPOSITION COMPRISING 7-HYDROXY DHEA AND/OR 7-KETO DHEA AND AT LEAST A 5α-REDUCTASE INHIBITOR |
| 06/20/2002 | WO2002047643A1 Water-free skin care formulations comprising micronized urea and method of manufacturing the same |
| 06/20/2002 | WO2002047642A1 Hypoallergenic and non-irritant skin care formulations |
| 06/20/2002 | WO2002047631A1 Composition, in particular cosmetic, containing 7-hydroxy dhea and/or 7-keto dhea and at least an isoflavonoid |
| 06/20/2002 | WO2002030888A3 Tricyclic compounds and uses thereof |
| 06/20/2002 | WO2002028905A3 Human anti-cd40 antibodies |
| 06/20/2002 | WO2002024681A3 Pyrazine derivatives as modulators of tyrosine kinases |
| 06/20/2002 | WO2001087977A3 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 06/20/2002 | WO2001085942A3 Cytoskeleton-associated proteins |
| 06/20/2002 | WO2001085096A3 Mast cell regulation |
| 06/20/2002 | WO2001079487A3 Polydesoxyribonucleotides for inhibiting the expression of the icam-1-gene |
| 06/20/2002 | WO2001072830A3 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 06/20/2002 | WO2001068851A3 Polypeptides and nucleic acids encoding same |
| 06/20/2002 | WO2001060326A3 Cosmetic or pharmaceutical composition containing sesquiterpene lactone |
| 06/20/2002 | WO2001052837A3 Use of at least a fatty ester for preparing a composition designed to inhibit 5-$g(a)-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive |
| 06/20/2002 | WO2001044445A8 Human lyases and associated proteins |
| 06/20/2002 | WO2001003688A3 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 06/20/2002 | WO2000067734A3 Use of phthalazine derivatives |
| 06/20/2002 | WO2000061750A9 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 06/20/2002 | WO2000061596A8 50 human secreted proteins |
| 06/20/2002 | US20020077461 Pharmaceutical formulation |
| 06/20/2002 | US20020077360 Administering to a mammal a retinoid campound which binds specifically or selectively to a RAR alpha retinoid receptors in preference over RAR beta and RAR Gamma retinoid receptors, for therapy and prophylaxisof disease or condition |
| 06/20/2002 | US20020077356 Nonsteroidal antiinflammatory agents |
| 06/20/2002 | US20020077344 For therapy and prophylaxis of high blood pressure, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, cardiac infarct, vascular restenosis after angioplasty, cardiomyopathies, endothelial dysfunction |
| 06/20/2002 | US20020077343 H2 receptor antagonist compounds in combination with nitric oxide donors, compostions and methods of use |
| 06/20/2002 | US20020077337 Chemical compounds |
| 06/20/2002 | US20020077333 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (TNF-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (COX-2) |
| 06/20/2002 | US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis |
| 06/20/2002 | US20020077304 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 06/20/2002 | US20020077277 Method of treating chronic ulcers |
| 06/20/2002 | US20020077256 Novel detergent compositions with enhanced depositing, conditioning and softness capabilities |
| 06/20/2002 | US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 06/20/2002 | US20020076783 Plants and plants cells expressing histidine tagged intimin |
| 06/20/2002 | US20020076766 Novel glucosaminidase |
| 06/20/2002 | US20020076705 Nucleotide sequences which code preferential polypeptide; for use in the detection, treatment, and prevention of alzheimer's, parkinson's, huntington's, Tourette Syndrome, meningitis, encephalitis, congenital disorders and brain |
| 06/20/2002 | US20020076457 Extracts of plants of genus Euphorbia, in particular sap of Euphorbia peplus, Euphorbia hirta and/or Euphorbia drummondii; selective cytotoxicity against malignant melanomas and squamous cell carcinomas |
| 06/20/2002 | US20020076450 Cosmetic containing plant extracts, particularly with a depigmenting, anti-radical and anit-ageing action |
| 06/20/2002 | US20020076445 Eukaryotic cells and method for preserving cells |
| 06/20/2002 | US20020076423 Cosmetic or dermatological formulations for the care and cooling of the skin after sunbathing |
| 06/20/2002 | US20020076395 Modified adipose tissue and related implants and methods |
| 06/20/2002 | US20020076389 Cosmetic and dermatological preparation with a content of cyclodextrins for the removal of sebum |
| 06/20/2002 | DE10063344A1 Photoprotective cosmetic or dermatological emulsion comprises 2,2'-(1,4-phenylene)bis(benzimidazole-3,5-disulfonic acid) and a partially neutralized saturated fatty acid mono- and/or diglyceride citrate ester |
| 06/20/2002 | DE10063343A1 Photoprotective cosmetic or dermatological emulsion comprises an asymmetric triazine ultraviolet filter and a partially neutralized saturated fatty acid mono- and/or diglyceride citrate ester |
| 06/20/2002 | DE10063173A1 Harnstoff- und Urethanderivate Urea and urethane |
| 06/20/2002 | DE10063130A1 Verwendung von Polyurethanen zur Verbesserung der Wasserfestigkeit kosmetischer oder dermatalogischer Formulierungen Use of polyurethanes to improve the water resistance of cosmetic formulations or dermatalogischer |
| 06/20/2002 | DE10062401A1 Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA Use of folic acid and / or derivatives thereof for producing cosmetic or dermatological preparations for the prevention of damage to the skin's DNA and / or repair of already occurred damage to the skin's DNA |